Autopsy report · NCT01786395
Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Cause of deathNo reason given
Life of this trial
- Registered 2 months before it started.
- 202 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- R-Tech Ueno, Ltd.
- Sponsor type
- Industry
- Conditions
- Retinitis Pigmentosa
- Interventions
- UF-021; Placebo
- Participants
- 202
- Sites
- 34
- Countries
- Japan
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.